Last quarter (Q3 2022), BIO-key International's total revenue was $1.37M, an increase of 5.75% from the same quarter last year. In Q3, BIO-key International's net income was $-2.40M. See BIO-key International’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 6.20M	$ 5.11M	$ 2.84M	$ 2.27M	$ 4.04M	$ 6.30M
Cost of Revenue	$ 1.83M	$ 1.67M	$ 794.83K	$ 2.46M	$ 4.16M	$ 3.24M
Gross Profit	$ 4.37M	$ 3.44M	$ 2.04M	$ -193.72K	$ -119.65K	$ 3.06M
Operating Expense	$ 11.49M	$ 8.44M	$ 6.90M	$ 6.37M	$ 6.75M	$ 7.34M
Operating Income	$ -7.12M	$ -5.00M	$ -4.86M	$ -6.56M	$ -6.87M	$ -4.28M
Net Non Operating Interest Income Expense	$ -3.10K	$ -13.93K	$ -4.31M	$ -1.07M	$ 80.00	$ 27.00
Other Income Expense	$ -180.00K	$ -50.00K	$ -499.08K	$ -6.96M	-	-
Pretax Income	$ -7.15M	$ -5.07M	$ -9.67M	$ -14.59M	$ -6.87M	$ -4.28M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -7.15M	$ -5.07M	$ -9.79M	$ -14.59M	$ -8.50M	$ -5.04M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 13.31M	$ 10.12M	$ 7.70M	$ 8.83M	$ 10.91M	$ 10.58M
Net Income From Continuing And Discontinued Operation	$ -7.15M	$ -5.07M	$ -9.67M	$ -14.59M	$ -6.87M	$ -4.28M
Normalized Income	$ -7.12M	$ -5.02M	$ -9.17M	$ -7.63M	$ -6.87M	$ -4.28M
Interest Expense	$ 3.61K	$ 18.00K	$ 4.34M	$ 1.07M	$ 0.00	-
EBIT	$ -7.15M	$ -5.05M	$ -5.33M	$ -13.52M	$ -6.87M	$ -4.28M
EBITDA	$ -6.60M	$ -4.53M	$ -4.90M	$ -12.51M	$ -5.26M	$ -2.70M

Currency in USD

BIO-key International Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing